Reasons for ineligibility in phase 1 and 2A HIV vaccine clinical trials at Kenya AIDS vaccine initiative (KAVI), Kenya.

Reasons for ineligibility in phase 1 and 2A HIV vaccine clinical trials at Kenya AIDS vaccine initiative (KAVI), Kenya.

With the persistent challenges towards controlling the HIV epidemic, there is an ongoing need for research into HIV vaccines and drugs. Sub-Saharan African countries--worst affected by the HIV pandemic--have participated in the conduct of clinical trials for HIV vaccines. In Kenya, the Kenya AIDS Va...

Full description

Bibliographic Details
Main Authors: Gloria S Omosa-Manyonyi, Walter Jaoko, Omu Anzala, Hilda Ogutu, Sabina Wakasiaka, Roselyn Malogo, Jacqueline Nyange, Pamela Njuguna, Jeckoniah Ndinya-Achola, Kirana Bhatt, Bashir Farah, Micah Oyaro, Claudia Schmidt, Frances Priddy, Patricia Fast
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3024980?pdf=render

Internet

http://europepmc.org/articles/PMC3024980?pdf=render

Similar Items